• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerosis leading to stenosis of the internal carotid artery is the underlying cause of 8–
15% of ischaemic strokes (symptomatic carotid stenosis). 1–2% of the adult population have …

Each section has been revised or rewritten and five new sections added:(i) management of
free floating thrombus (section 4.13),(ii) management of carotid webs (section 4.14),(iii) …

Background The optimal treatment for patients with asymptomatic carotid artery stenosis is
under debate. Since best medical treatment (BMT) has improved over time, the benefit of …

Background Transcarotid artery revascularization (TCAR) was approved by the Food and
Drug Administration in 2015 for patients with carotid artery stenosis. However, no …

Significant advances in the field of carotid artery stenting (CAS) have occurred, including
new randomized trial data, recent professional societal statements for competency, new …

Background: Single-cohort studies suggest that second-generation stents (SGS;“mesh
stents”) may improve carotid artery stenting (CAS) outcomes by limiting peri-and …

Carotid stenosis (CS) is a buildup of atherosclerotic plaque within the artery leading to a
wide range of symptoms, from mild symptoms, including blurred vision and confusion, to …

Carotid artery stenosis is a leading cause of ischemic stroke. While management of
symptomatic carotid stenosis is well established, the optimal approach in asymptomatic …

Background: To compare safety and efficacy between carotid artery stenting (CAS) and
carotid endarterectomy (CEA) in treating asymptomatic carotid artery stenosis based on …